Algert Global LLC Buys 5,094 Shares of Exponent, Inc. (NASDAQ:EXPO)

Algert Global LLC boosted its stake in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 23.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,139 shares of the business services provider’s stock after acquiring an additional 5,094 shares during the period. Algert Global LLC owned 0.05% of Exponent worth $2,581,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Comerica Bank increased its holdings in shares of Exponent by 8.7% in the first quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock worth $19,112,000 after purchasing an additional 18,429 shares during the last quarter. Eagle Asset Management Inc. grew its holdings in Exponent by 40.2% during the 4th quarter. Eagle Asset Management Inc. now owns 85,303 shares of the business services provider’s stock valued at $7,510,000 after buying an additional 24,455 shares in the last quarter. Silvercrest Asset Management Group LLC increased its stake in Exponent by 6.8% in the 1st quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock worth $22,864,000 after acquiring an additional 17,496 shares during the last quarter. UBS Group AG raised its holdings in shares of Exponent by 41.4% during the 4th quarter. UBS Group AG now owns 76,565 shares of the business services provider’s stock worth $6,741,000 after acquiring an additional 22,410 shares in the last quarter. Finally, Congress Asset Management Co. MA boosted its position in shares of Exponent by 30.3% during the 4th quarter. Congress Asset Management Co. MA now owns 52,157 shares of the business services provider’s stock valued at $4,592,000 after acquiring an additional 12,138 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Truist Financial restated a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Get Our Latest Stock Report on EXPO

Exponent Trading Down 1.8 %

Shares of NASDAQ:EXPO opened at $113.17 on Wednesday. The company has a market cap of $5.74 billion, a price-to-earnings ratio of 57.16 and a beta of 0.66. Exponent, Inc. has a 12 month low of $64.61 and a 12 month high of $115.61. The company has a 50-day moving average price of $106.54 and a 200 day moving average price of $96.42.

Exponent (NASDAQ:EXPOGet Free Report) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. The business had revenue of $132.43 million during the quarter, compared to analyst estimates of $130.83 million. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period last year, the company earned $0.50 EPS. As a group, equities analysts forecast that Exponent, Inc. will post 2.04 EPS for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend was Friday, September 6th. Exponent’s payout ratio is 56.57%.

Insider Buying and Selling at Exponent

In related news, VP John Pye sold 3,956 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now directly owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.10% of the company’s stock.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.